Maribel Adame, PhD

In the European Union, mortality rates for all cancers fell by 10% in men and 8% in women. Declines were more significant throughout Europe in populations ages 35 to 44, at 25% for men and 20% for women, according to a report published online in the Annals of Oncology (November 30, 2009).
The researchers attributed adoption of standard therapeutic protocols to reducing mortality from Hodgkin’s lymphomas, leukemias, and testicular cancers. They also believe that advancements in integrated treatments have reduced breast, colorectal, ovarian, and prostate cancer mortality.